Meeder Asset Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,036
Closed -$254K 2186
2022
Q3
$254K Sell
1,036
-31
-3% -$8.37K 0.01% 530
2022
Q2
$264K Buy
1,067
+67
+7% +$18.1K 0.02% 545
2022
Q1
$331K Buy
+1,000
New +$308K 0.02% 525
2021
Q4
Sell
-101
Closed -$33K 2514
2021
Q3
$33K Sell
101
-35
-26% -$11.9K ﹤0.01% 1238
2021
Q2
$42K Buy
136
+1
+0.7% +$307 ﹤0.01% 1192
2021
Q1
$43K Sell
135
-356
-73% -$114K ﹤0.01% 1162
2020
Q4
$159K Sell
491
-2,126
-81% -$588K 0.04% 345
2020
Q3
$725K Buy
2,617
+36
+1% +$10.4K 0.05% 285
2020
Q2
$624K Sell
2,581
-392
-13% -$78.7K 0.04% 323
2020
Q1
$432K Buy
2,973
+2,314
+351% +$384K 0.03% 365
2019
Q4
$113K Buy
659
+657
+32,850% +$122K 0.01% 758
2019
Q3
$0 Sell
2
-247
-99% -$53.4K ﹤0.01% 2307
2019
Q2
$65K Buy
249
+34
+16% +$9.02K ﹤0.01% 879
2019
Q1
$61K Sell
215
-3,137
-94% -$1.04M ﹤0.01% 825
2018
Q4
$1.09M Hold
3,352
0.1% 180
2018
Q3
$1.51M Buy
3,352
+478
+17% +$188K 0.11% 161
2018
Q2
$1.18M Buy
2,874
+1,545
+116% +$560K 0.1% 181
2018
Q1
$387K Buy
1,329
+10
+0.8% +$2.53K 0.04% 371
2017
Q4
$246K Buy
1,319
+1,298
+6,181% +$242K 0.02% 441
2017
Q3
$4K Buy
+21
New +$3.17K ﹤0.01% 1341
2016
Q3
Sell
-1,761
Closed -$192K 990
2016
Q2
$192K Sell
1,761
-5,671
-76% -$564K 0.02% 572
2016
Q1
$705K Sell
7,432
-29,285
-80% -$2.47M 0.07% 294
2015
Q4
$3.31M Buy
36,717
+19,855
+118% +$1.68M 0.3% 87
2015
Q3
$1.56M Buy
+16,862
New +$1.49M 0.15% 157

Other funds holding ABMD

Meeder Asset Management's ABMD Position: Q4 2022 in Review

Meeder Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,036 shares — an estimated $254K sold.

Meeder Asset Management first reported a position in ABMD in Q3 2015 and held it in 24 quarters. The position peaked at $3.31M in Q4 2015. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Meeder Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 1,036 Abiomed Inc shares in Q4 2022, an estimated $254K.
  • Meeder Asset Management first reported a position in Abiomed Inc in Q3 2015 and held it in 24 quarters.
  • Meeder Asset Management's Abiomed Inc position peaked at $3.31M in Q4 2015.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.